Though yielding slightly inconclusive results, a new study demonstrates that ICIs can still provide an alternative option for Taiwanese melanoma patients seeking a robust response profile with tolerable toxicity.
Use of ICIs for Advanced Melanoma in Taiwanese Patients
Monya De, MD MPH 